Benzinga | Nov 5, 2020 08:10AM EST

Catalyst Biosciences Q3 EPS $(0.73) Up From $(1.06) YoY, Sales $893.00M

Catalyst Biosciences (NASDAQ:CBIO) reported quarterly losses of $(0.73) per share. This is a 31.13 percent increase over losses of $(1.06) per share from the same period last year. The company reported $893.00 million in sales this quarter.